Motion Syros: A Study to Investigate the Efficacy of Tradipitant in

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04196933` - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma	N/A
Recruiting	`NCT06128707` - Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study
Completed	`NCT05611814` - Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms	N/A
Recruiting	`NCT06106256` - Three-Axis Wearable Adaptive Vestibular Stimulator	N/A
Completed	`NCT02839135` - A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.	Phase 1
Completed	`NCT04420949` - Sensory Training for Visual Motion Sickness	N/A
Completed	`NCT04184115` - Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness	Phase 3
Completed	`NCT03988530` - Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects	Phase 3
Terminated	`NCT04219982` - DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness	Phase 2/Phase 3
Terminated	`NCT02155309` - Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray	Phase 2/Phase 3
Completed	`NCT04947423` - Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion	Phase 3
Recruiting	`NCT05903924` - Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness	Phase 3
Recruiting	`NCT04999449` - Nebulizer Delivery of Intranasal Scopolamine	Phase 1
Recruiting	`NCT05886660` - Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance	Phase 2
Completed	`NCT03755596` - Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness	Phase 4
Recruiting	`NCT05628220` - Motion Sickness Desensitization Using VR	N/A
Recruiting	`NCT06138613` - Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness	Phase 3
Completed	`NCT06232785` - Gynecologic Endoscopic Surgery of Female Motion Sickness Patients	Phase 4
Completed	`NCT06056622` - Motion Sickness Rehabilitation for Virtual Reality	N/A
Withdrawn	`NCT04331561` - Sensory Training for Orientation and Balance	N/A

NCT number	NCT04327661
Study type	Interventional
Source	Vanda Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	February 26, 2020
Completion date	April 12, 2023

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms